Patients With Schizophrenia, Relatives
Conditions
Keywords
schizophrenia, environmental factors
Brief summary
Schizophrenia is a chronic and severe mental disorder with a lifetime prevalence of about 1 per cent, the symptoms can be very disabling and causing a heavy medical and socioeconomic. There are significant variations from one population to another. Clinical manifestations of schizophrenia (symptoms, evolution, severity of disability) are highly variable. This variability, both epidemiological and clinical, is due to genetic and environmental factors. Environmental factors may be either risk factors or modifying factors (changing clinical presentation but do not alter the risk of disease) for schizophrenia. Environmental risk factors have been identified (eg: urbanity, cannabis, migration), but the investigators don't know neither the components directly responsible, nor the mechanisms by which they increase the risk of schizophrenia. To date, there is no study has systematically evaluated the role of environmental modifying factors in schizophrenia. Environmental factors may be individual, unique to each person (eg cannabis, migration.), or population-based (eg ethnic density, socio-economic difficulties.) The identification/ identifying of environmental risk factors or modifiers, both individual and population, may have theoretical implications (understanding of etiopathogenic mechanisms) and practical (implementation of preventive measures). The potential effectiveness of preventive measures is even greater than the risk attributable to certain environmental factors is important. Most studies on environmental factors in schizophrenia were conducted in Anglo-Saxon countries and northern Europe, but no study of these risk factors has been conducted in France. There are important differences environment based on study populations, these results are not generalizable to other countries, including France.
Interventions
For schizophrenic's patients, specific assessment will be perform
Sponsors
Study design
Eligibility
Inclusion criteria
All subjects * Age \> 18 years * Somatic state / condition and level of understanding (language, intellectual level) compatible with the data collection (interview, self-administered questionnaires) Patients * Diagnosis of schizophrenia according to DSM-IV criteria * Living in catchment areas Non-Inclusion Criteria: All subjects * Not affiliated to the social security scheme * inability to provide informed consent * Decompensated schizophrenic underway Relatives * Protective Measures (tutor, curator)
Exclusion criteria
Patients * The diagnosis of psychotic disorder is not confirmed by the synthesis of all clinical data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of schizophrenia (according to Diagnostic and Statistical Manual of Mental Disorders (DSM IV)) will be estimated from the census population-unit (unit TRIRIS INSEE) | 56 months, From March 2014 to November 2018 |
| The frequency of populational risk factors (insecurity, disorganization and density of migrants) will be assessed from the variables of INSEE | 56 months, From March 2014 to November 2018 |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of individual risk factors (migration, cannabis, seasonality of birth, childhood trauma, social environment) will be measured from standardized assessments | 56 months, From March 2014 to November 2018 |
Countries
France